National Cancer Institute
The National Cancer Institute (NCI), a prominent entity in cancer research and treatment, is headquartered in Egypt (EG) and serves as a leading institution in the Middle East and North Africa. Founded in 1969, the NCI has made significant strides in oncology, focusing on cancer prevention, diagnosis, and therapy. As a key player in the healthcare industry, the NCI offers a range of services, including advanced cancer treatment, clinical trials, and educational programmes aimed at improving patient outcomes. Its commitment to research and innovation has positioned it as a trusted authority in cancer care, contributing to notable advancements in the field. With a reputation for excellence, the NCI continues to play a vital role in the fight against cancer, making it a cornerstone of the Egyptian healthcare landscape.
DitchCarbon Score
How does National Cancer Institute's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
National Cancer Institute's score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
National Cancer Institute's reported carbon emissions
The National Cancer Institute (NCI), headquartered in EG, currently does not have available data on carbon emissions, as no specific emissions figures have been provided. Consequently, there are no documented reduction targets or climate commitments outlined in their initiatives. In the absence of concrete emissions data, it is essential to note that many organisations in the healthcare sector are increasingly recognising the importance of addressing climate change and its impact on public health. While the NCI has not specified its climate commitments or reduction strategies, the broader industry context suggests a growing trend towards sustainability and carbon footprint reduction. As the NCI continues to engage in cancer research and public health initiatives, it may consider establishing measurable climate goals in line with industry standards to contribute to global efforts in mitigating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
National Cancer Institute is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
